Human CD270,TNFRSF14,HVEM recombinant protein

Reference:
Size

100ug, 50ug

Brand

Product type

Host Species

Applications

,

Product nameHuman CD270,TNFRSF14,HVEM recombinant protein
Uniprot IDQ92956
Uniprot linkhttp://www.uniprot.org/uniprot/Q92956
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
SequenceMEPPGDWGPPPWRSTPKTDVLRLVLYLTFLGAPCYAPALPSCKEDEYPVGSECCPKCSPGYRVKEACGELTGTVCEPCPPGTYIAHLNGLSKCLQCQMCDPAMGLRASRNCSRTENAVCGCSPGHFCIVQDGDHCAACRAYATSSPGQRVQKGGTESQDTLCQNCPPGTFSPNGTLEECQHQTKCSWLVTKAGAGTSSSHWVGSHHHHHH
Molecular weight22.46kDa
Protein delivered with Tag?Yes
Purity estimated40%
BufferPBS, pH 7.5
FormLyophilized
Delivery conditionDry Ice
Delivery lead time in business days5-7
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesMammalian cells
ApplicationsELISA,WB
Fragment TypePartial
Aliases /SynonymsTumor necrosis factor receptor superfamily member 14,Herpes virus entry mediator A,Herpesvirus entry mediator A,HveA,Tumor necrosis factor receptor-like 2,TR2,D270
ReferencePX-P4039
NoteFor research use only

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Human CD270,TNFRSF14,HVEM recombinant protein”

Your email address will not be published. Required fields are marked *

Related products

Pidilizumab Biosimilar – Anti-PDCD1, CD279 mAb – Research Grade
Biosimilar

Pidilizumab Biosimilar – Anti-PDCD1, CD279 mAb – Research Grade

PX-TA1312 400€
Varlilumab Biosimilar – Anti-CD27, TNFRSF7 mAb – Research Grade
Biosimilar

Varlilumab Biosimilar – Anti-CD27, TNFRSF7 mAb – Research Grade

PX-TA1352 400€
Atezolizumab Biosimilar – Anti-CD274, B7-H1, PDL1 mAb – Research Grade
Biosimilar

Atezolizumab Biosimilar – Anti-CD274, B7-H1, PDL1 mAb – Research Grade

PX-TA1367 300€
Enoblituzumab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade
Biosimilar

Enoblituzumab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade

PX-TA1410 400€
Prezalumab Biosimilar – Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb – Research Grade
Biosimilar

Prezalumab Biosimilar – Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb – Research Grade

PX-TA1417 400€
Camrelizumab Biosimilar – Anti-PDCD1, PD-1, CD279 mAb – Research Grade
Biosimilar

Camrelizumab Biosimilar – Anti-PDCD1, PD-1, CD279 mAb – Research Grade

PX-TA1445 300€
Gilvetmab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar

Gilvetmab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade

PX-TA1467 400€
Tislelizumab Biosimilar – Anti-PDCD1, PD1,  CD279 mAb – Research Grade
Biosimilar

Tislelizumab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade

PX-TA1479 400€
Spartalizumab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar

Spartalizumab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade

PX-TA1483 300€
Vopratelimab Biosimilar – Anti-ICOS, CD278 mAb – Research Grade
Biosimilar

Vopratelimab Biosimilar – Anti-ICOS, CD278 mAb – Research Grade

PX-TA1505 400€
Cetrelimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar

Cetrelimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade

PX-TA1513 400€
Budigalimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar

Budigalimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade

PX-TA1523 400€
Cemiplimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar

Cemiplimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade

PX-TA1524 400€
Dostarlimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar

Dostarlimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade

PX-TA1526 400€
CD70 antigen (CD70)
Ligand

CD70 antigen (CD70)

PX-P4642 210€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products